Longitudinal assessment of circulating fibroblast activation protein in systemic sclerosis-associated interstitial lung disease. - Broens B; van der Laken CJ; Simons IA; Dekker T; Duitman JW; Voskuyl AE (Arthritis research & therapy, 2025)